MedTrace Logo

Effects of Oxytocin on Hemodynamics in Patients Undergoing Laparoscopic Myomectomy

NCT04109339 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-09-30

No results posted yet for this study

Summary

This project will study the effect of oxytocin on hemodynamics in patients undergoing laparoscopic myomectomy, and how to prevent and manage such hemodynamic changes effectively.It provides a reference for the rational use of oxytocin in clinical practice, which can not only effectively contract the uterus and reduce bleeding, but also reduce the influence on hemodynamics.

Conditions

  • Oxytocin
  • Hemodynamic Monitoring
  • Laparoscopic Surgery

Interventions

DRUG

Oxytocin

During the laparoscopic hysteromyomectomia operation, different doses of oxytocin was used with different routs.

Sponsors & Collaborators

  • Yangzhou University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2019-12-31
Completion
2020-10-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04109339 on ClinicalTrials.gov